Asset Details
Do you wish to reserve the book?
Effect of favipiravir and an anti-inflammatory strategy for COVID-19
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Effect of favipiravir and an anti-inflammatory strategy for COVID-19
Do you wish to request the book?
Effect of favipiravir and an anti-inflammatory strategy for COVID-19
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Effect of favipiravir and an anti-inflammatory strategy for COVID-19
2020
Overview
Coronavirus disease 2019 (COVID-19) presents a complex pathology including inflammation, endothelial damage, thrombus formation, and acute respiratory failure [2,3,4] This syndrome requires complex treatment to reduce viral genome amounts, anti-inflammatory drugs, and anticoagulation. COVID-19 was diagnosed with real-time reverse transcriptase-polymerase chain reaction in approved laboratories from nasopharyngeal and throat swabs and with lung computed tomography. The treatment protocol was completed without any clinically important change in 2 patients with bronchial asthma, one with rheumatoid arthritis (early-stage steroid administration) and one with bleeding complication (without heparin).
Publisher
BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
